ClinicalTrials.gg
CompletedNCT06264128Updated Dec 11, 2024Results posted

TPAP for Comfort in OSA

An interventional study of TPAP and CPAP in Obstructive Sleep Apnea, sponsored by SleepRes Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by SleepRes Inc. · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 755 studies in Sleep Apnea, Obstructive with a site in United States — 127 open to participants now, 162 under way, 9 of them phase 3. Sleep Apnea, Obstructive · United States.

Enrollment
114th of 596
150 · median 49
Started
2024
with 41 others
No phase
412 of 755
68 open now
Registered
650th of 755
by date

Among the 755 studies in Sleep Apnea, Obstructive with a site in United States, this one is the 114th largest by enrollment of the 596 interventional ones that give a count, is one of 42 that started in 2024, is one of 412 with no phase, and was the 650th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

127 of the 755 studies in Sleep Apnea, Obstructive with a site in United States are open now. Recruiting first, the newest first:

122 more — sign in →

All 127 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 755 studies in Sleep Apnea, Obstructive with a site in United States, or all of them as a file.
02

Study summary

TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the pressure from the set pressure at the beginning of inspiration and does not return the pressure to the full set level until about halfway through expiration. The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort vs. CPAP during supine wakefulness.

Read the detailed description

The TheraPAP Comfort Study is an in-office study to assess comfort of TPAP vs. CPAP in CPAP-naïve patients with OSA during supine wakefulness. Patients will be recruited after routine outpatient visits. They will be asked to breath normally for approximately 1 minute in supine wakefulness while being administered background CPAP (at 9 or 13 cmH2O) or TPAP at various pressure drops. TPAP drops will be administered in a paired comparison before or/and after each corresponding CPAP level, according to a randomized design. Eventually, 6 one-to-one comparisons (TPAP vs. corresponding background CPAP or TPAP vs. TPAP) will be made, 3 per each randomized order. As an example, CPAP 9 will be compared to TPAP 1/1 cmH2O drops; CPAP 9 will be compared to TPAP 2/2 cmH2O drops; and TPAP 1/1 cmH2O drops will be compared to TPAP 2/2 cmH2O drops in a random sequence.

03

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • CPAP
  • comfort
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 - 70 age range
  • AHI (apnea/hypopnea index) > 10 on a previous HST (Home Sleep Test)
  • CPAP-naive participants
  • (Body Mass Index) >= 18 kg/m\^2

Exclusion criteria

Exclusion Criteria:

  1. Current sleep disorder other than OSA (Obstructive Sleep Apnea) of a severity that would interfere with study participation or interpretability of data (including central sleep apnea, per central AHI > 5 events/h).
  2. Any chronic lung diseases.
  3. Chronic oxygen therapy.
  4. A serious illness or infection in the past 30 days as determined by investigator.
  5. Patients with hypoglossal nerve stimulation implant.
  6. Any non-previously mentioned vulnerable population.
  7. Any condition that in the investigator's opinion would present an unreasonable risk to the participant, or which would interfere with their participation in the study or confound study interpretation.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    CPAP v TPAP

    Participants will compare CPAP to 2 different levels of TPAP, then will compare 2 levels of TPAP against each other by breathing on each pair of therapies for a minute or so, then deciding which is more comfortable or if they are equivalent.

    Device: TPAP · Device: CPAP

Interventions

  • DeviceTPAP

    TPAP is a form of CPAP therapy where the therapy pressure is reduced from the beginning of inhalation through mid or later exhalation. The "CPAP" therapy pressure is only present at the end of the expiratory phase.

  • DeviceCPAP

    CPAP is a standard formal at home therapy for obstructive sleep apnea where a device attached via a facemask applies a constant pressure to a patient's lungs during sleep. It is the reference standard in this study.

06

What researchers measure

Primary outcomes

  1. CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O

    Compare the comfort level of CPAP at 9 cmH2O against TPAP dropped by 2+2 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

  2. CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+3 cmH2O

    Compare the comfort level of CPAP at 13 cmH2O against TPAP dropped by 2+3 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

Secondary outcomes

  1. CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

  2. CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+1 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

  3. CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

  4. CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O

    Time frame: All tests conducted in a 20 minute time frame on awake supine patients.

07

Results

Posted Dec 11, 2024

Participant flow

Participant flow — Overall Study
MilestoneSequence 1Sequence 2
Started7476
Completed7476
Not completed00

Outcome measures

PrimaryCPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O

Compare the comfort level of CPAP at 9 cmH2O against TPAP dropped by 2+2 cmH2O

Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 9 cmH2O )
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O69.3 (61 to 77)
PrimaryCPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+3 cmH2O

Compare the comfort level of CPAP at 13 cmH2O against TPAP dropped by 2+3 cmH2O

Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+3 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 13 cmH2O )
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+3 cmH2O84 (77 to 89)
SecondaryCPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O
Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 9 cmH2O )
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O45.6
SecondaryCPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+1 cmH2O
Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+1 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 9 cmH2O )
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+1 cmH2O56
SecondaryCPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O
Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 13 cmH2O )
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O45.8
SecondaryCPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O
Time frame:
All tests conducted in a 20 minute time frame on awake supine patients.
Reported as:
Number · percentage of total participants
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O
percentage of total participantsCPAP vs. TPAP (Baseline Pressure: 13 cmH2O )
CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O38.5

Adverse events

Collected over 20 minute office visit. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
TPAP0/150 (0%)0/150 (0%)0/150 (0%)
CPAP0/150 (0%)0/150 (0%)0/150 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Overall Group
Mean43 ± 11
Sex: Female, Male
Sex: Female, Male(Participants)Overall Group
Female85
Male65
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Overall Group
American Indian or Alaska Native1
Asian2
Native Hawaiian or Other Pacific Islander0
Black or African American17
White123
More than one race0
Unknown or Not Reported7
08

Study locations

1 site
  • SleepCenters of Middle Tennessee
    Murfreesboro, Tennessee 37129, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — We only plan to share the results after we publish them.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2024 to primary completion in May 2024, 2 months.

Results were first posted in Dec 2024, 6 months after primary completion.

Of 118 industry-sponsored interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 2 months is below that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2024
First posted
Feb 16, 2024
StartActual
Mar 8, 2024
Primary completionActual
May 25, 2024
CompletionActual
May 25, 2024
Results first posted
Dec 11, 2024
Last update
Dec 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06264128
Lead sponsor
SleepRes Inc.
Responsible party
Sponsor
First posted
Feb 16, 2024
Start date
Mar 8, 2024
Primary completion
May 25, 2024
Completion
May 25, 2024
Results posted
Dec 11, 2024
Last update
Dec 11, 2024

Study contacts

Abinash Joshi, MD
principal investigator · University of Louisville

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion